R&D Funding, Epidemiology And Balanced Policies To Fuel India Growth - CII Lifescience Conclave
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Establishment of a new global disease detection center for epidemiology studies in India, a unique government funding method to boost innovation, and academic partnerships were among the prominent discussion topics at the Annual LifeScience Conclave, organized by the Confederation of Indian Industry in the capital city
You may also be interested in...
WHO Delists Panacea Biotec's Combination Vaccines From Pre-qualified List; Move Comes A Year After Action Against Sanofi's Shantha Unit
MUMBAI - In a stern signal intended to ensure product quality, the World Health Organization delisted combination vaccines made by Indian vaccine maker Panacea Biotec Ltd. from its list of pre-qualified suppliers
Indian Government In Dilemma As DCGI's Competence Is Questioned Amid Mounting Criticism
MUMBAI - An eerie uncertainty looms over the future of India's highest and most powerful drug authority, the Drug Controller General of India, as the government was challenged last week against its decision to grant a nine-month service term extension to the present incumbent Surinder Singh
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).